2 07, 2018 Laura Boldrini et. al, Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients Diatech Pharmacogenetics2018-08-27T14:08:51+02:00 Leggi di più
26 06, 2018 Iván Prieto Potin et. al, Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer Diatech Pharmacogenetics2018-08-27T13:18:01+02:00 Leggi di più
19 06, 2018 Luca Reggiani Bonetti et. al, Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer Diatech Pharmacogenetics2018-08-27T12:54:22+02:00 Leggi di più
2 06, 2018 Jasna Metovic et. al, Safe transportation of formalin-fixed liquid-free pathology specimens Diatech Pharmacogenetics2018-06-05T09:58:38+02:00 Leggi di più
23 05, 2018 Sabrina Arena et. al, Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer Diatech Pharmacogenetics2018-05-30T15:25:25+02:00 Leggi di più
14 05, 2018 Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. Diatech Pharmacogenetics2018-05-30T15:42:21+02:00 Leggi di più
6 04, 2018 Valeria Maffeis et. al, Onycholemmal carcinoma: A case report with its molecular profiling Diatech Pharmacogenetics2018-04-12T15:41:02+02:00 Leggi di più
27 03, 2018 Claudia Rengucci et. al, Stool DNA Integrity Method for Colorectal Cancer Detection Diatech Pharmacogenetics2018-04-12T14:44:23+02:00 Leggi di più
26 03, 2018 Roberta Minari et. al, Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in NSCLC EGFR-mutated patient. Diatech Pharmacogenetics2018-04-12T14:59:43+02:00 Leggi di più
9 03, 2018 Lorena Gurrieri et. al, MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme” Diatech Pharmacogenetics2018-04-12T15:39:06+02:00 Leggi di più